An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid

Osteoarthritis and Cartilage

Volumn 21, Issue 7, 2013, Pages 918-922

  Beekhuizen, M ^a   Gierman, L M ^b,c   van Spil, W E ^a   Van Osch, G J V M ^d   Huizinga, T W J ^c   Saris, D B F ^a,e   Creemers, L B ^a   Zuurmond, A M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Chemokines; Cytokines; Growth factors; Synovial fluid

Indexed keywords

CD40 LIGAND; CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 6; LEPTIN; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PLATELET DERIVED GROWTH FACTOR AA; RANTES;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFLAMMATION; KNEE OSTEOARTHRITIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PRINCIPAL COMPONENT ANALYSIS; SYNOVIAL FLUID;

EID: 84879460748     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.04.002     Document Type: Article

References (12)

1. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
2. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23:471-478.
3. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049.
4. de Jager W., Prakken B., Rijkers G.T. Cytokine multiplex immunoassay: methodology and (clinical) applications. Methods Mol Biol 2009, 514:119-133.
5. Vangsness C.T., Burke W.S., Narvy S.J., MacPhee R.D., Fedenko A.N. Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis - a pilot study. Bull NYU Hosp Jt Dis 2011, 69:122-127.
6. Hunter D.J., Felson D.T. Osteoarthritis. BMJ 2006, 332:639-642.
7. Scotece M., Conde J., Gomez R., Lopez V., Lago F., Gomez-Reino J.J., et al. Beyond fat mass: exploring the role of adipokines in rheumatic diseases. ScientificWorldJournal 2011, 11:1932-1947.
8. Yuan G.H., Masuko-Hongo K., Sakata M., Tsuruha J., Onuma H., Nakamura H., et al. The role of C-C chemokines and theirreceptors in osteoarthritis. Arthritis Rheum 2001, 44:1056-1070.
9. Tang C.H., Hsu C.J., Fong Y.C. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Arthritis Rheum 2010, 62:3615-3624.
10. Alaaeddine N., Olee T., Hashimoto S., Creighton-Achermann L., Lotz M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 2001, 44:1633-1643.
11. Blom A.B., van der Kraan P.M., van den Berg W.B. Cytokine targeting in osteoarthritis. Curr Drug Targets 2007, 8:283-292.
12. Burger D., Dayer J.M., Palmer G., Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis?. Best Pract Res Clin Rheumatol 2006, 20:879-896.